Researchers Tease Out Glitches in Immune System's Self-Recognition
News Nov 22, 2014
Immunity is a thankless job. Though the army of cells known as the immune system continuously keeps us safe from a barrage of viruses, bacteria and even precancerous cells, we mainly notice it when something goes wrong: “Why did I get the flu this year even though I got vaccinated?” “Why does innocent pollen turn me into a red-eyed, sniffling mess?”
A new study from Johns Hopkins takes a big step toward answering this and other questions about immunity, shedding light on how the body recognizes enemies on the molecular level - and how that process can go wrong. The results appear Nov. 21, in the online journal Nature Communications.
In the laboratory of Scheherazade Sadegh-Nasseri, Ph.D., a professor of immunology and pathology at the Johns Hopkins University School of Medicine, research centers on how the immune system “selects” bits of protein to become so-called dominant epitopes. It’s these red flags that white blood cells will be programmed to fight. Sadegh-Nasseri’s research team spent years devising a mixture of proteins and chemicals that replicates the complex cellular processing that yields the dominant epitopes.
“We wanted to know how one particular epitope becomes the dominant one that white blood cells look for when they’re battling a given foe,” Sadegh-Nasseri says.
Postdoctoral fellow AeRyon Kim, Ph.D., explains that the epitope-generating system enabled her and others on Sadegh-Nasseri’s team to discriminate differences in the selection processes for proteins from pathogenic microbes versus human proteins: “We found that epitopes from human proteins that are associated with autoimmune diseases, like diabetes and rheumatoid arthritis, are generated through a different process than are proteins from pathogens.”
The pathogen-derived epitopes bind to protein receptors that protect them from the specialized processing enzymes that chop them up, the research group found. However, autoimmune-causing epitopes are resistant to destruction by those enzymes even without protection by their receptor proteins.
Ultimately, Kim says, “When a critical mass of one epitope accumulates, it becomes dominant.” The dominant epitope is then “presented” to newly minted T cells, which trains them to either destroy the foe or attack the body’s own cells, ultimately causing inflammation.
“Knowing how these dominant epitopes arise - and having a system that lets us predict which will be dominant - is a big step toward understanding the roots of autoimmune diseases,” says Sadegh-Nasseri. “It could also help in training the immune system - for example, in vaccine development.”
Macrophage's Role in Maintaining Tattoos Could Hold Key to RemovalNews
Researchers have discovered that, though a tattoo may be forever, the skin cells that carry the tattoo pigment are not. Instead, the cells can pass on the pigment to new cells when they die. The study suggests ways to improve the ability of laser surgery to remove unwanted tattoos.READ MORE
New Causes of Cellular Decline in Prematurely Aging Kids DiscoveredNews
In a recent paper published in Cell Reports, Saint Louis University researchers have uncovered new answers about why cells rapidly age in children with a rare and fatal disease. The data points to cellular replication stress and a mistaken innate immune response as culprits, and the team found success in the laboratory in blocking these processes with vitamin D.READ MORE
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018